* Patient-specific titanium implant designed for cranial and craniofacial reconstruction * Fi...
* 74 healthcare professionals from 13 countries attended, recognizing the value of Prabotulinumto...
* Korea–Thailand spine experts jointly lead advanced training on endoscopic spine surgery and lat...
* Third Independent Data Monitoring Committee (IDMC) review confirms safety and continuation of t...
* More than 80% relative bioavailability compared with injectable obesity therapy, well above the...
- The collaboration combines Salipro Biotech's unique expertise and its Salipro® platform technolog...
- The bone graft incorporating rhBMP-2 has received FDA IDE approval for a pivotal clinical trial i...
SEOUL, South Korea, Dec. 31, 2024 /PRNewswire/ -- CG MedTech (f/k/a Innosys, CEO Ju Mi Chung), a lea...
- At "AMWC SEA 2024," one of the world's top three aesthetic medicine congresses, the Nabota booth ...
MILAN, Oct. 10, 2024 /PRNewswire/ -- Daewoong Pharmaceutical (Co-CEOs Seongsoo Park and Chang-jae L...
SEOUL, South Korea, July 29, 2024 /PRNewswire/ -- Daewoong Pharmaceutical (Co-CEOsChang-Jae Lee and...
SEOUL, South Korea, May 14, 2024 /PRNewswire/ -- CGBio, a leading medical device company, announced...
SEOUL, South Korea, Nov. 28, 2023 /PRNewswire/ -- Daewoong Pharmaceutical is pleased to announce th...
'Fexuprazan,' Novel drug for Gastroesophageal Reflux Disease, starts its release inthe Philippines....
– Daewoong Pharmaceutical, "Expecting the smooth approval with the successful phase 3 clinical tria...
SEOUL, South Korea, July 19, 2023 /PRNewswire/ -- Daewoong Pharmaceutical obtained approval for a S...
* Elucidated molecular mechanism behind safety and efficacy of Bersiporocin * Bersiporocin is cu...
- New investigational data evaluating Fexuprazan in a Korean clinical trial program for healing er...
- Exclusive rights for the development and commercialization of DWP213388 in the global market to V...
SEOUL, South Korea, April 24, 2023 /PRNewswire/ -- The research results of Daewoong Pharmaceutical'...